Abdul Kadir Al Muhaidib & Sons Company v Dr Moamena Kamel, Dr. Hend El Sherbini and Hena Holdings Ltd

JurisdictionBritish Virgin Islands
CourtHigh Court (British Virgin Islands)
JudgeMithani, J.
Judgment Date29 January 2026
Neutral CitationVG 2026 HC 3
Year2026
Docket NumberBVICH (COM) 2024/0213
Abdul Kadir Al Muhaidib & Sons Company
and
Dr Moamena Kamel, Dr. Hend El Sherbini and Hena Holdings Limited

Mithani, J. KC (Ag.)

BVICH (COM) 2024/0213

High Court

Appearances:

Mr. Robert Nader and Mr. Gareth Timms, both of forbes Hare, for the Claimant.

Mr. George Spalton KC, instructed by Mourant Ozannes, and with him, Mr. Shane Donovan and Ms. Marija Emberson, both of Mourant Ozannes, for the First and Second Defendants.

Ms. Sara-Jane Knock of Withers for the Third Defendant.

INTRODUCTION
1

Mithani, J. KC (AG.): In this Claim (“the Claim”, “this Claim” or “these Proceedings”), issued on 3 July 2024, the Claimant is Abdul Kadir Al Muhaidib and Sons Company. I will refer to it in this judgment (“this Judgment” or “the Judgment”) as either the “Claimant” or “Abdul Kadir”.

2

The Defendants in the Claim are Dr. Moamena Kamel (“Dr. Kamel” or “the First Defendant”), Dr. Hend El Sherbini (“Dr. Sherbini” or the “Second Defendant”) and Hena Holdings Ltd. (“Hena” or the “Third Defendant”). The Third Defendant takes a neutral stance in the Claim. It is, therefore, represented separately from the First and Second Defendants. I shall refer to the First and Second Defendants in this Judgment as “the Defendants”, which expression, where the context requires, will also include the Third Defendant.

3

I will refer to the Claimant and the Defendants collectively as “the Parties”.

4

The substantive relief that the Claimant seeks from this court (“this Court or the Court”) is set out in the amended Statement of Claim in the following terms:

  • “(a) an order declaring, pursuant to Part 43.10 11–12 of the Eastern Caribbean Supreme Court Civil Procedure Rules (Revised Edition) 2023 (which applies by virtue of section 104 of the Act) and section 81(1) and/or section 84(1) of the Act that the arbitration award dated 20 October 2022 issued by the Cairo Regional Centre for International Commercial Arbitration … in favour of the Claimant against, inter alia, the First and Second Defendants … shall be enforceable against the First and Second Defendants in the same manner as if the award was [sic] a judgment or an order of the court that has the same effect;

  • (b) an order granting the Claimant permission to enforce the [said] award as to the amount remaining unpaid thereunder as if those amounts had been ordered to be paid by the First and Second Defendants to the Claimant pursuant to a judgment or an order of the Court;

  • (c) a freezing injunction against the First, Second and Third Defendants pursuant to section 17.1(1) and 51.2(3) of the Eastern Caribbean Supreme Court Civil Procedural Rules (Revised Edition) 2023 and the appointment of a receiver over the First and Second Defendants' legal and beneficial interests in the shares of the Third Defendant pursuant to section 51.1(1) of the Eastern Caribbean Supreme Court Civil Procedural Rules (Revised Edition) 2023 …”

5

In addition to the above definitions, I will, for the large part, adopt the definitions and abbreviations used in the documents included in the bundles lodged for the hearing on 27 and 29 January 2026 (“the Hearing”) for the purposes of this Judgment. Any underlined emphasis appearing in this Judgment is my own. All other emphasis — whether in bold, italics, or otherwise — reflects the original emphasis as it appears in the source materials reproduced from the Bundles and remains that of the respective authors or creators of those documents.

BACKGROUND
6

The dispute between the parties has a long, complicated, and chequered history. It only needs to be referred to briefly for the purpose of this Judgment.

7

Abdul Kadir is a joint stock company incorporated in the Kingdom of Saudi Arabia. Dr. Kamel and Dr. Sherbini are Egyptian nationals and Professors of Clinical Pathology at Cairo University. Dr. Kamel is the mother of Dr. Sherbini. Abdul Kadir operates, among other things, as a private equity group with investments in medical, diagnostic, and analytical laboratory services in the Middle East and North Africa.

8

Al Mokhtabar Medical Laboratories Company (“Al Mokhtabar”) is a leading Egyptian medical testing company, incorporated as a joint-stock company in 2004. At all material times prior to 2012, its issued share capital was held exclusively by the First Defendant, the Second Defendant, and Mr. Mahmoud Abdel Meguid (“MAM”), now deceased.

9

By 2007, Al Mokhtabar had undergone significant commercial expansion within Egypt and across North Africa. In order to support further growth and regional expansion, the Defendants and MAM sought external investment and entered into discussions with the Claimant.

10

On 20 November 2007, the Claimant, the First and Second Defendants, and MAM executed a Memorandum of Understanding (“the MOU”). The MOU contemplated a transaction under which the Claimant would acquire a 49% shareholding in Al Mokhtabar.

11

The MOU expressly provided that, as a condition precedent to its effectiveness and enforceability, the issued share capital of Al Mokhtabar would be increased to Egyptian pounds (EGP) 11,435,000, divided into 1,143,500 nominal shares, in accordance with the transaction structure set out in it.

12

Clause 4 of the MOU provided that the aggregate purchase price for the proposed 49% shareholding was EGP 58 million, of which EGP 17 million was payable in cash upon execution of the MOU. The Claimant paid that sum shortly after signature.

13

The MOU further contemplated the completion of legal and financial due diligence by the Claimant within 15 days of execution, and the execution of a definitive share purchase agreement within 45 days of the date of the MOU.

14

The MOU stipulated that all dealings under it were governed by Egyptian law.

15

Clause 25 of the MOU contained an arbitration clause providing for arbitration in Cairo under the rules of the Cairo Regional Centre for International Commercial Arbitration (“CRCICA”), with the award to be final and binding. The terms of clause 25 were as follows:

“This MOU and the relationship between the Parties shall be governed by, and construed in accordance with, the laws of the Arab Republic of Egypt. Any dispute arising out of or in connection with the interpretation or the execution of this Agreement, including any question regarding its existence, validity, interpretation, performance or termination, or any action taken hereunder, shall be settled by Arbitration, which may be initiated by either Party by sending the other Party a written notice according to the following conditions:

  • a. The arbitration shall take place in Cairo, Egypt before the CRCICA according to the CRCICA [R]ules of arbitration applicable at the time of the dispute.

  • b. The number of arbitrators shall be 3 (three). Each Party (being the Sellers as one party and [t]he purchasers is the other party) shall appoint one arbitrator, the chosen arbitrators shall appoint the third arbitrator (umpire).

  • c. The language of the arbitration shall be English.

  • d. The arbitral award shall be final, binding on the Parties and subject to no appeal.”

16

Following the execution of the MOU, disputes arose between the parties concerning the satisfaction of the condition precedent, the provision of due diligence materials, and the restructuring steps required to effect the proposed share transfer.

17

The Claimant maintained that it had fulfilled its contractual obligations under the MOU, including payment of the EGP 17 million, and asserted that the Defendants and MAM had failed to perform their obligations. The Defendants, by contrast, maintained that the condition precedent relating to the increase of Al Mokhtabar's share capital had not been fulfilled and that the MOU had therefore not become effective or enforceable.

18

On 13 May 2008, the Claimant wrote to the Defendants and MAM, asserting a breach of the MOU and threatening to commence arbitration proceedings pursuant to Clause 25.

19

On 20 May 2008, the Defendants responded in writing, stating that the MOU was not yet effective and that, as a consequence, the arbitration clause was likewise inoperative. They stated that any claims should be brought before the competent Egyptian courts.

20

Between June and July 2008, the Claimant served a series of judicial notices upon the Defendants and MAM. Those notices included express statements that the Claimant accepted what it described as the Defendants' waiver of the arbitration clause contained in the MOU.

21

From 2008 onwards, multiple proceedings were commenced in the Egyptian courts by both sides, arising out of or connected with the MOU and the proposed acquisition of shares in Al Mokhtabar.

22

In July 2008, the Claimant commenced proceedings seeking the appointment of a judicial receiver over Al Mokhtabar. That claim was eventually struck out on procedural grounds.

23

In April 2009, the Claimant commenced proceedings in the Cairo Economic Court seeking declarations about the validity and enforceability of the MOU and orders enabling it to acquire the 49% shareholding.

24

On 28 January 2010, the Cairo Economic Court held that the MOU constituted a valid contract but did not amount to an effective sale contract capable of specific performance. The Claimant's claim for transfer of shares was dismissed.

25

The Claimant appealed that decision to the Egyptian Court of Cassation (“CC”). On 24 May 2014, the CC dismissed the appeal, thereby confirming that the MOU was not enforceable as a share sale agreement.

26

In December 2012, notwithstanding the ongoing court proceedings, the Claimant commenced arbitration proceedings before the CRCICA pursuant to clause 25 of the MOU.

27

On 23 January 2014, the arbitral tribunal issued an award declining jurisdiction. The tribunal held that, by their correspondence and judicial notices in 2008, the parties had agreed to waive the arbitration agreement contained in the MOU.

28

Thereafter, further litigation ensued in the...

Get this document and AI-powered insights with a free trial of vLex and Vincent AI

Get Started for Free

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex

Unlock full access with a free 7-day trial

Transform your legal research with vLex

  • Complete access to the largest collection of common law case law on one platform

  • Generate AI case summaries that instantly highlight key legal issues

  • Advanced search capabilities with precise filtering and sorting options

  • Comprehensive legal content with documents across 100+ jurisdictions

  • Trusted by 2 million professionals including top global firms

  • Access AI-Powered Research with Vincent AI: Natural language queries with verified citations

vLex